Begin main content

Call for Patient Input and Clinical Experts: Vascepa

May 17, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Vascepa Generic name icosapent ethyl Manufacturer HLS Therapeutics Indication(s) Ischemic events in statin-treated patients Project Number SR0619-000 Call for patient input 2019-05-17 Patient input deadline 2019-07-09 Submit patient input Submit Register as Clin...

New at CADTH - May 2019

May 7, 2019
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

Calls for Patient Input: Benlysta, Onstryv and Takhzyro

April 30, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Benlysta Generic name belimumab Manufacturer GlaxoSmithKline Inc. Indication(s) Systemic lupus erythematosus Project Number SR0616-000 Call for patient input 2019-04-30 Patient input deadline 2019-06-19 Submit patient input Submit Register as Clinical Expert Reg...

Call for Patient Input and Clinical Experts: Verkazia

April 23, 2019
CADTH has received the following notice(s) of pending drug submission(s). Brand name Verkazia Generic name cyclosporine Manufacturer Santen Inc. Indication(s) Severe vernal keratoconjunctivitis, pediatric (≥4 years) Project Number SR0615-000 Call for patient input 2019-04-23 Patient input deadline 2019-06-12 Submit patient input Submit Register ...

Pharmaceutical Reviews Update 7

April 17, 2019
See Pharmaceutical Reviews Update – Issue 7 for important news and information regarding CADTH’s drug review programs. This issue includes changes to the CADTH Common Drug Review procedure to include an additional embargo period for CDEC recommendations that have been substantially revised following a request for reconsideration by manufacturers...